Top brokers name 3 ASX shares to sell next week

Brokers aren't feeling overly positive on these shares…

| More on:
Model bear in front of falling line graph, cheap stocks, cheap ASX shares

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that investors might want to hear about are summarised below. Here's why top brokers think investors ought to sell these shares next week:

Ansell Limited (ASX: ANN)

According to a note out of Macquarie, its analysts have retained their underperform rating and cut the price target on this health and safety products company's shares to $30.70. This follows the release of an update at its annual general meeting. Macquarie notes that Ansell will need a big second half to achieve consensus estimates. However, it doesn't appear confident it will be able to deliver on this. The Ansell share price ended the week at $30.51.

Ramsay Health Care Limited (ASX: RHC)

A note out of Morgan Stanley reveals that its analysts have retained their underweight rating and $60.00 price target on this private hospital operator's shares. Its analysts were not surprised by Ramsay's weak first quarter update last week which revealed a 1.3% increase in first quarter revenue to $3.2 billion but a 39.5% decline in quarterly profit after tax to $58.1 million. Morgan Stanley had been anticipating a disappointing result due to margin pressures. The Ramsay share price was fetching $68.50 at Friday's close.

Wesfarmers Ltd (ASX: WES)

Analysts at Citi have retained their sell rating but lifted their price target on this conglomerate's shares to $50.00. This follows news that Wesfarmers has signed an agreement to acquire pharmacy chain operator and distributor Australian Pharmaceutical Industries Ltd (ASX: API). Although the broker expects the deal to give its earnings a small boost, it isn't enough for a change of recommendation. Citi believes that Wesfarmers' shares are overvalued at the current level. The Wesfarmers share price was trading at $59.42 at the end of the week.

Should you invest $1,000 in Ansell Limited right now?

Before you buy Ansell Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Ansell Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool Australia has recommended Ansell Ltd. and Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man in a blue collared shirt sits at his desk doing a single fist pump as he watches the Appen share price rise on his laptop
Broker Notes

These ASX 200 stocks could rise 30% to 40%

Analysts are tipping these shares to go to the moon. Let's find out why.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man pointing at a blue rising share price graph.
Technology Shares

Up 30% in a month, this ASX 200 tech share is 'a compelling opportunity': expert

Analysts from listed investment company WAM Capital say this ASX 200 tech stock is worth watching.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

View of a mine site.
Broker Notes

How much upside does Macquarie tip for Deterra Royalties shares?

Deterra Royalties offers ASX investors a different way to invest in global mining.

Read more »

Woman with $50 notes in her hand thinking, symbolising dividends.
Broker Notes

Broker reveals outlook for ASX dividend shares amid volatile market

Peter Gardner from Plato Investment Management tells ASX investors where to look for dividend income this year.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker puts buy rating on Zip shares

Big returns could be on offer for investors according to its analysts.

Read more »

gaming asx share price rise represented by slot machine paying jackpot
Broker Notes

What does Macquarie expect from Aristocrat Leisure shares when it reports on 14 May?

Here's what the broker is expecting from this gaming technology company next week.

Read more »